Veracyte | VCYT - Market Capitalization

Stock Price
38.40
Daily Change
2.68 7.50%
Monthly
-3.52%
Yearly
13.48%
Q1 Forecast
34.53

Veracyte reported $2.8B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 204M 164M Jun/2025
Agilent USD 35.57B 2.29B Feb/2026
Anika Therapeutics USD 379M 166M Jun/2025
Arrowhead Research USD 8.04B 973M Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Exact Sciences USD 10.36B 334M Sep/2025
Heron Therapeutics USD 145M 6M Sep/2023
Illumina USD 21.21B 588M Feb/2026
Intrexon USD 363M 69M Sep/2023
Laboratory Of America USD 23.77B 2.98B Feb/2026
Ligand Pharmaceuticals USD 3.39B 24M Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
Rigel Pharmaceuticals USD 188M 36M Sep/2023
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 196.26B 4.94B Feb/2026
Sonic Healthcare AUD 12.87B 105.69M Jun/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Veracyte USD 2.8B 526M Feb/2026
Waters USD 19.14B 3.47B Feb/2026